Covaxin was opposed by the West, Indian liberals, and medical journals. Covaxin won
Immediately after receiving a much-delayed Emergency Use authorization (EUA) approval from World Health Organisation (WHO) medical journal Lancet has now stated that the made-in-India vaccine is 77.8 per cent effective against symptomatic ...